Blephamide

Blephamide is a brand name of prednisolone/sulfacetamide sodium ophthalmic, approved by the FDA in the following formulation(s):

BLEPHAMIDE (prednisolone acetate; sulfacetamide sodium - suspension; ophthalmic)

• 
  Manufacturer: ALLERGAN
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 0.2%;10% ^[RLD]

Has a generic version of Blephamide been approved?

No. There is currently no therapeutically equivalent version of Blephamide available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Blephamide. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Blephamide.

See also...

• Blephamide Suspension Consumer Information (Wolters Kluwer)
• Blephamide Consumer Information (Cerner Multum)
• Prednisolone/Sulfacetamide Drops Consumer Information (Wolters Kluwer)
• Prednisolone/Sulfacetamide Ointment Consumer Information (Wolters Kluwer)
• Prednisolone/Sulfacetamide Suspension Consumer Information (Wolters Kluwer)
• Sulfacetamide and prednisolone ophthalmic Consumer Information (Cerner Multum)